Cochlear Implant in Chennai (2025) | Nucleus Nexa System | Dr. Sanjeev Mohanty

How Cochlear’s Nucleus Nexa System Is Redefining Hearing Care

By Dr. Sanjeev Mohanty, Senior Consultant & Head of ENT, MGM Healthcare, Chennai  |  10 min read

Specialisation: ENT / Otorhinolaryngologist & Head and Neck Surgeon  |  Serving Chennai, Bhubaneswar, Tamil Nadu, Odisha, Siliguri & across India

Introduction: A Hearing Crisis That India Can No Longer Ignore

According to the World Health Organization (WHO), over 430 million people worldwide live with disabling hearing loss. In India alone, that number exceeds 63 million — making hearing loss one of the country’s most prevalent yet undertreated health conditions. Families in Chennai, Bhubaneswar, Tamil Nadu, Odisha, and Siliguri know this reality firsthand.

The frustration I hear most often in my clinic at MGM Healthcare, Chennai is this: ‘We waited too long because we didn’t know there was a solution.’ Hearing loss is invisible. It creeps in gradually. And for too many children across Tamil Nadu, Odisha, and eastern India, it robs them of language, learning, and connection before anyone realises what is happening.

Today, that story can have a very different ending. In July 2025, Cochlear Limited received FDA approval for the Nucleus Nexa System — the world’s first and only smart cochlear implant system. This is not simply a better device. It is a generational shift in what cochlear implant technology in India can deliver.

Many patients also ask:  What exactly makes the Nucleus Nexa System ‘smart’? Read on for the full explanation.

 

TL;DR — Quick Summary •        The Cochlear Nucleus Nexa System is the world’s first smart cochlear implant with upgradeable firmware, internal memory for hearing settings, and AI-powered Dynamic Power Management. •        It is now FDA-approved and available in India through specialist ENT centres including MGM Healthcare, Chennai. •        Cochlear implants are the gold-standard treatment for severe-to-profound sensorineural hearing loss in both children and adults. •        Early implantation in children — ideally before 12 months of age — delivers the best speech and language outcomes. •        Dr. Sanjeev Mohanty, Senior ENT Consultant at MGM Healthcare Chennai, provides end-to-end cochlear implant care for patients from Chennai, Bhubaneswar, Tamil Nadu, Odisha, Siliguri and across India. •        Government support is available through the ADIP Scheme for eligible children. Most major insurance providers now cover cochlear implantation.

 

What Is a Cochlear Implant? (Simple Explanation)

FEATURED SNIPPET ANSWER What is a cochlear implant? A cochlear implant is a small electronic medical device surgically placed inside the inner ear (cochlea) to restore the sensation of sound in people with severe-to-profound sensorineural hearing loss. Unlike a hearing aid, which amplifies sound, a cochlear implant bypasses damaged hair cells in the cochlea and directly stimulates the auditory nerve, sending sound signals to the brain. It consists of two parts: an internal implant placed surgically, and an external sound processor worn behind or on the ear.

 

To understand why the Nucleus Nexa System is so significant, it helps to understand how cochlear implants work and who they are designed for.

Key Terms Defined

Cochlea: The snail-shaped structure in the inner ear responsible for converting sound vibrations into nerve signals.

Sensorineural hearing loss: The most common type of permanent hearing loss, caused by damage to the hair cells in the cochlea or the auditory nerve. It cannot be corrected with surgery or medication, but can be treated with cochlear implants.

Sound processor: The external component of a cochlear implant system, worn behind or on the ear, which captures sound and transmits it to the internal implant.

MAPs (hearing maps): The personalised programming settings created by an audiologist for each cochlear implant recipient, calibrated to their specific hearing needs.

Firmware: The embedded software that controls the operation of a device. In the Nucleus Nexa System, the implant’s firmware can be updated wirelessly — a world first.

 

Hearing Aid vs. Cochlear Implant	Key Differences
Amplifies existing sound	Bypasses damaged cochlea entirely
Suitable for mild-moderate loss	Designed for severe-to-profound loss
No surgery required	Requires surgical implantation
Removes when sleeping	Implant is permanent; processor removable
Technology is external only	Nexa: technology upgradeable inside implant

 

Many patients also ask:  Is a cochlear implant better than a hearing aid for all types of hearing loss?

Not for everyone. Hearing aids remain the right choice for mild to moderate hearing loss. Cochlear implants are specifically recommended when hearing aids no longer provide sufficient benefit — typically for severe-to-profound sensorineural hearing loss. A proper audiological evaluation is the only way to determine which is right for you or your child.

 

What Is the Cochlear Nucleus Nexa System? The World’s First Smart Cochlear Implant

FEATURED SNIPPET ANSWER What makes the Cochlear Nucleus Nexa System ‘smart’? The Cochlear Nucleus Nexa System is the world’s first cochlear implant with upgradeable firmware built into the implanted device itself. This means the implant — like a smartphone — can receive wireless software updates that unlock new hearing features over time, without any additional surgery. It also stores personalised hearing settings (MAPs) in its internal memory, manages battery life intelligently through Dynamic Power Management, and includes onboard diagnostic capability. It received FDA approval in 2025 and is available in India through specialist ENT centres.

Every cochlear implant that existed before the Nucleus Nexa System shared the same fundamental limitation: the implanted device was static. Once surgically placed, it could never be updated. All innovation had to live in the external sound processor. Patients wanting to benefit from new processing technology had to replace their external device. The implant itself — the component that lasts a lifetime — was frozen in time.

The Nucleus Nexa System changes this permanently. Here is what makes it genuinely revolutionary.

Smart Feature 1: Upgradeable Firmware on the Implant

For the first time in cochlear implant history, the internal device runs its own firmware — a software layer embedded in a completely redesigned chipset inside the implant. Cochlear Limited can push firmware updates wirelessly that improve the way the implant processes and transmits sound to the auditory nerve, just as a smartphone operating system receives updates that improve performance and add features.

Why this matters for Indian patients: A patient implanted in Chennai or Bhubaneswar today does not need to worry that their device will be technologically obsolete in five years. The Nexa System is built to improve alongside the science of hearing, across the full lifetime of the implant.

Smart Feature 2: Internal Memory for Hearing Settings

The Nucleus Nexa Implant is the first cochlear implant to store personalised hearing settings (MAPs) securely within the implant’s own memory. This has significant practical implications. If a sound processor is lost, damaged, or needs replacement — a genuine concern for active patients and children across Tamil Nadu, Odisha, and Siliguri — the hearing settings are preserved inside the implant and can be instantly transferred to any replacement Nucleus Nexa Sound Processor.

Smart Feature 3: Dynamic Power Management

An intelligent algorithm runs continuously on the implant, analysing the listening environment in real time and adapting the system’s power consumption accordingly. The result is all-day battery life in the smallest and lightest sound processor currently available on the market — 9% smaller and 12% lighter than its predecessor. For children at school in Chennai or patients commuting in Bhubaneswar, this means seamless, all-day hearing without battery anxiety.

Smart Feature 4: Onboard Diagnostics

The system continuously monitors its own performance, running self-checks that reduce the frequency of in-clinic diagnostic visits and give audiologists richer performance data during follow-up appointments. Clinical guidelines recommend regular audiological monitoring after cochlear implantation; onboard diagnostics make this process more efficient and accurate.

 

KEY STATISTICS & CLINICAL EVIDENCE •        The Nucleus Nexa System is the world’s first cochlear implant with upgradeable implant firmware, approved by the FDA in 2025. (Cochlear Limited, 2025) •        The Nucleus 8 Nexa Sound Processor is 9% smaller and 12% lighter than its predecessor. (Cochlear Limited clinical data, 2025) •        Over 430 million people globally live with disabling hearing loss. (World Health Organization, 2021) •        Up to 80% of children implanted before 12 months of age achieved receptive vocabulary within the normal range by school entry. (Dettman et al., Otology & Neurotology, 2016)

 

“The Nucleus Nexa Implant is the first ever cochlear implant running its own firmware. Similar to smartphones, the implant firmware can be updated to enable new features and access future innovations. Recipients will now have access to their best possible hearing experience with both implant and sound processor updates.” — Jan Janssen, Chief Technology Officer, Cochlear Limited

 

Who Is a Candidate for Cochlear Implant Surgery in India?

FEATURED SNIPPET ANSWER Who qualifies for cochlear implant surgery in India? Cochlear implants are recommended for adults and children with severe-to-profound sensorineural hearing loss who gain limited or no benefit from conventional hearing aids. Children can be evaluated as early as 6 months of age — and the earlier the implantation, the better the speech and language outcomes. Adults with post-lingual hearing loss (deafness that occurred after speech development) also achieve significant quality-of-life improvements. Candidacy is determined through comprehensive audiological evaluation, imaging (CT or MRI), and medical assessment.

 

Candidacy in Children

Medical guidelines recommend that cochlear implant evaluation begin as early as 6 months of age for infants who fail newborn hearing screening or are diagnosed with severe-to-profound sensorineural hearing loss. The developmental science is unambiguous: the earlier a child receives a cochlear implant, the greater the neuroplasticity of the auditory pathway and the richer the speech and language outcome.

According to long-term studies published in Otology & Neurotology, up to 80% of children who received cochlear implants before 12 months of age demonstrated receptive vocabulary within the normal range by school entry. Across Tamil Nadu, Odisha, and eastern India, where access to specialist ENT care has historically been limited, this evidence makes early evaluation life-changing.

Many patients also ask:  At what age can my child receive a cochlear implant in India?

Most guidelines support cochlear implantation from 6 to 12 months of age for children with confirmed profound bilateral sensorineural hearing loss. At Dr. Mohanty’s clinic at MGM Healthcare, Chennai, we work with a multidisciplinary team to evaluate infants and young children from across Tamil Nadu, Odisha, Siliguri, and Bhubaneswar. Earlier is almost always better.

Candidacy in Adults

Adults with severe-to-profound sensorineural hearing loss — whether the hearing loss developed gradually or suddenly — are strong candidates for cochlear implantation. Post-lingual adults (those who developed speech before losing hearing) typically achieve the best outcomes. However, even adults with pre-lingual or long-standing profound deafness benefit meaningfully from cochlear implantation, particularly in their ability to detect environmental sounds and improve speech reading.

Common Misconceptions About Cochlear Implant Candidacy

Misconception 1: ‘My child is too young for a cochlear implant.’ Reality: Early implantation is strongly recommended. The brain’s auditory pathways are most receptive to stimulation in the first two years of life.

 

Misconception 2: ‘Cochlear implants only work for children.’ Reality: Clinical studies consistently show significant benefits for adults across all age groups, including the elderly.

 

Misconception 3: ‘I can’t afford a cochlear implant in India.’ Reality: The Government of India’s ADIP Scheme provides subsidised cochlear implants for eligible children. CGHS and major private insurance providers increasingly cover cochlear implantation costs.

 

Misconception 4: ‘I live in Odisha / Siliguri — this surgery isn’t accessible to me.’ Reality: Dr. Mohanty’s team at MGM Healthcare, Chennai welcomes patients from Bhubaneswar, Odisha, Siliguri, and across India, with structured support for out-of-city patients.

How to Get a Cochlear Implant in India: Step-by-Step Guide

If you are searching for cochlear implant surgery in Chennai, Bhubaneswar, Tamil Nadu, Odisha or Siliguri, this is exactly what the process looks like from first appointment to long-term follow-up.

 

1

Step 1: Recognise the Signs of Significant Hearing Loss In adults: difficulty following conversations, asking people to repeat themselves, relying on lip reading, social withdrawal, turning up TV volume excessively. In children: not responding to name, delayed speech milestones, inattentiveness in school, behavioural changes. If you recognise any of these signs in yourself or your child, seek evaluation immediately. Hearing loss compounds over time; early intervention consistently delivers better outcomes.

 

2

Step 2: Request a Comprehensive Audiological Evaluation A pure tone audiogram, speech discrimination test, and age-appropriate hearing assessment will determine the type and degree of hearing loss. At MGM Healthcare, Chennai, Dr. Mohanty’s team conducts a full audiological workup for patients from across Tamil Nadu, Bhubaneswar, Odisha, and Siliguri.

 

3

Step 3: Undergo Cochlear Implant Candidacy Assessment If audiological results suggest severe-to-profound sensorineural hearing loss with inadequate benefit from hearing aids, a formal cochlear implant candidacy evaluation is initiated. This includes a hearing aid trial period (typically 3-6 months), speech perception testing, psychological evaluation, and family counselling.

 

4	Step 4: Pre-Surgical Imaging and Medical Clearance A high-resolution CT scan of the temporal bone confirms cochlear anatomy is suitable for electrode insertion. In some cases, an MRI is also performed. General fitness for anaesthesia is assessed by the medical team.

 

5

Step 5: Choose Your Cochlear Implant System Dr. Mohanty will guide you through the available options, including the Cochlear Nucleus Nexa System — the world’s first smart cochlear implant now available in India. The right choice depends on audiological profile, age, lifestyle, and long-term hearing goals.

 

6

Step 6: Cochlear Implant Surgery The procedure is performed under general anaesthesia and typically takes 1.5 to 2 hours. The Nucleus Nexa Implant is placed behind the ear, and the electrode array is gently inserted into the cochlea. Dr. Sanjeev Mohanty performs cochlear implant surgery using advanced microsurgical techniques at MGM Healthcare, Chennai — one of India’s leading ENT centres.

 

7

Step 7: Sound Processor Activation (Switch-On) Approximately 2–4 weeks after surgery, the sound processor is activated and programmed by your audiologist. With the Nucleus Nexa System, personalised hearing settings (MAPs) are stored inside the implant itself. Patients often describe their first activation as an emotional and transformative experience.

 

8

Step 8: Auditory Rehabilitation and Long-Term Follow-Up Speech therapy and auditory training are essential following cochlear implant activation, particularly for children. The Nucleus Nexa System’s firmware upgradability means the implant can continue to improve over time through wireless updates. Dr. Mohanty’s clinic provides ongoing follow-up support for patients from Chennai, Bhubaneswar, Tamil Nadu, Odisha, Siliguri and across India.

 

Cochlear Implant Cost in India: What Patients Need to Know

FEATURED SNIPPET ANSWER What is the cost of cochlear implant surgery in India? Cochlear implant surgery in India involves the cost of the implant device, surgical fees, anaesthesia, hospitalisation, and post-operative audiological rehabilitation. Costs vary significantly based on the implant model, hospital, and city. The Government of India’s ADIP Scheme provides subsidised cochlear implants for children from economically weaker sections. CGHS and major private insurance providers now cover cochlear implant surgery. Contact Dr. Mohanty’s clinic at MGM Healthcare, Chennai for a personalised cost assessment and insurance eligibility guidance.

 

Cost is one of the most important questions families ask, and it deserves a transparent answer. Cochlear implant surgery in India is a comprehensive medical investment that includes the implant device (which itself varies in cost by model and generation), surgical fees, hospital stay, audiological programming, and rehabilitation.

Government Support: The ADIP Scheme

The Assistance to Disabled Persons (ADIP) Scheme, administered by the Ministry of Social Justice and Empowerment, provides cochlear implants free or at subsidised cost for children from below-poverty-line families. According to government guidelines, children up to 5 years of age with profound bilateral sensorineural hearing loss are eligible. Families from Odisha, Tamil Nadu, Bhubaneswar, Siliguri and across India can access this scheme through approved implant centres.

Insurance Coverage in India

Medical guidelines from major Indian insurance regulatory bodies now support cochlear implant coverage. CGHS (Central Government Health Scheme) covers cochlear implantation for eligible government employees and their families. Most large private insurers, including those active across Tamil Nadu and Odisha, have updated their policies to include cochlear implant surgery. Dr. Mohanty’s team can assist patients in understanding their coverage options.

Many patients also ask:  Does health insurance in India cover cochlear implant surgery for adults?

Coverage varies by insurer and policy type. CGHS covers cochlear implantation for eligible beneficiaries. Private insurers increasingly include cochlear implant surgery under surgical benefit riders or critical illness policies. It is worth contacting your insurer directly and requesting a pre-authorisation letter. Our team at MGM Healthcare, Chennai can provide the necessary medical documentation to support your claim.

Why Choose Dr. Sanjeev Mohanty for Cochlear Implant Surgery in India?

Choosing a cochlear implant surgeon is one of the most consequential decisions a family can make. The surgical expertise, the post-operative audiological team, and the long-term follow-up infrastructure all directly affect hearing outcomes.

About Dr. Sanjeev Mohanty •        Senior Consultant & Head of ENT Department, MGM Healthcare, Chennai — one of South India’s leading tertiary care hospitals. •        Extensive expertise as an ENT Surgeon / Otorhinolaryngologist and Head & Neck Surgeon with advanced cochlear implant surgical training. •        Access to the latest cochlear implant technology including the Cochlear Nucleus Nexa System — the world’s first smart cochlear implant, now available in India. •        Comprehensive multidisciplinary care: surgeon + specialist audiologist + speech-language therapist + rehabilitation team. •        Serving patients from Chennai, Tamil Nadu, Bhubaneswar, Odisha, Siliguri, and across India — with structured support for out-of-city and out-of-state patients. •        Telemedicine follow-up available for patients who cannot travel frequently to Chennai.

 

“The Nucleus Nexa Implant is innovative new technology that I am really excited about. The smart implant innovation further solidifies my confidence in being able to provide the best outcomes for my patients today and in the future.” — Dr. David Kelsall, Rocky Mountain Ear Center — reflecting the global clinical community’s response to the Nexa System

 

As an ENT specialist who has worked with patients from across Chennai, Bhubaneswar, Tamil Nadu, Odisha, and Siliguri, I have seen the transformative power of cochlear implantation firsthand. The Nucleus Nexa System gives me the confidence to tell every patient: the implant we place today will not become obsolete. It will evolve with you.

Hearing Loss in India: The Bigger Picture and the Road Ahead

India has one of the world’s highest burdens of preventable and treatable hearing loss. Yet cochlear implant penetration rates remain far below clinical need. The reasons include limited awareness, geographic access challenges (particularly in states like Odisha and regions like Siliguri), and historical cost barriers.

The National Programme for Prevention and Control of Deafness (NPPCD), launched by the Government of India, aims to reduce the prevalence and impact of hearing loss across the country. Combined with the ADIP Scheme and the expanding footprint of specialist ENT centres, the infrastructure for better cochlear implant access in Tamil Nadu, Odisha, Bhubaneswar, and Siliguri is growing.

The Nucleus Nexa System amplifies this progress. A device that improves through firmware updates is particularly valuable in regions where access to regular specialist follow-up is geographically challenging. The smarter the implant, the less dependent a patient needs to be on frequent in-clinic visits.

Key Takeaways •        The Cochlear Nucleus Nexa System is the world’s first smart cochlear implant — with upgradeable firmware, internal memory (MAPs), Dynamic Power Management, and onboard diagnostics. •        It is FDA-approved, available in India in 2025, and accessible through specialist ENT centres including MGM Healthcare, Chennai, under Dr. Sanjeev Mohanty. •        Cochlear implants are the clinically proven gold-standard treatment for severe-to-profound sensorineural hearing loss in both children and adults. •        Early implantation in children (before 12 months) produces the best outcomes: up to 80% achieve vocabulary within normal range by school age (Dettman et al., 2016). •        The ADIP Scheme provides subsidised cochlear implants for eligible children in India. CGHS and major private insurers now cover the procedure. •        Patients from Chennai, Bhubaneswar, Tamil Nadu, Odisha, Siliguri and across India can access evaluation and surgery through Dr. Mohanty’s team at MGM Healthcare, Chennai. •        Unlike previous implants, the Nucleus Nexa System is a future-ready platform — delivering continuous hearing improvements through wireless firmware updates without additional surgery.

 

FAQ Frequently Asked Questions — Cochlear Implant India

 

Structured for FAQPage JSON-LD schema  |  Google People Also Ask  |  Voice Search  |  AI Assistant Extraction

 

Q:  What is the Cochlear Nucleus Nexa System and is it available in India? A:  The Cochlear Nucleus Nexa System is the world’s first smart cochlear implant, approved by the FDA in 2025. It features upgradeable firmware, internal memory for personalised hearing settings, Dynamic Power Management for all-day battery life, and onboard diagnostics. It is now available in India through specialist ENT centres, including MGM Healthcare in Chennai under Dr. Sanjeev Mohanty.

 

Q:  What is the cost of cochlear implant surgery in India in 2025? A:  Cochlear implant costs in India include the device, surgery, hospitalisation, and rehabilitation. The ADIP Scheme provides subsidised devices for eligible children from below-poverty-line families. CGHS and major private insurers cover cochlear implantation. For a personalised cost assessment and insurance guidance, consult Dr. Sanjeev Mohanty at MGM Healthcare, Chennai.

 

Q:  Who is a good candidate for cochlear implant surgery in India? A:  Adults and children with severe-to-profound sensorineural hearing loss who gain little benefit from hearing aids are strong candidates. Children can be evaluated from 6 months of age — earlier implantation delivers better outcomes. Candidacy is determined through full audiological evaluation, imaging, and medical assessment at Dr. Mohanty’s clinic in Chennai.

 

Q:  Can a cochlear implant be upgraded without surgery? A:  Yes — with the Cochlear Nucleus Nexa System. It is the world’s first cochlear implant with upgradeable firmware, meaning future sound processing improvements are delivered wirelessly to the implanted device without any additional surgical procedure. This is a first in cochlear implant history.

 

Q:  Is cochlear implant surgery safe for children, and what are the outcomes? A:  Cochlear implant surgery is considered very safe and is performed routinely under general anaesthesia by specialist ENT surgeons. Clinical studies show that up to 80% of children implanted before 12 months reach receptive vocabulary within the normal range by school entry. The procedure is recommended by ENT specialists and audiologists as the standard of care for profound childhood deafness.

 

Q:  Is cochlear implant treatment available for patients from Bhubaneswar, Odisha, or Siliguri? A:  Yes. Patients from Bhubaneswar, Odisha, and Siliguri can access world-class cochlear implant surgery and evaluation through Dr. Sanjeev Mohanty at MGM Healthcare, Chennai. The clinic welcomes out-of-city patients and offers structured follow-up support, including telemedicine options for patients who cannot travel frequently.

 

Q:  What is the ADIP Scheme and how does it help with cochlear implant costs in India? A:  The ADIP (Assistance to Disabled Persons) Scheme is a Government of India programme that provides cochlear implants free or at subsidised cost for children under 5 years from below-poverty-line families with profound bilateral sensorineural hearing loss. It is accessible through approved cochlear implant centres across India, including Tamil Nadu, Odisha, and West Bengal.

 

Q:  How long does cochlear implant surgery take and what is the recovery period? A:  The surgery typically takes 1.5 to 2 hours under general anaesthesia. Most patients are discharged within 24–48 hours. The sound processor is activated approximately 2–4 weeks post-surgery. Full auditory rehabilitation through speech therapy continues for several months, with the most significant improvements seen in the first year, especially in children.

Conclusion: A Smarter Implant for a Better Hearing Life in India

Hearing is not just about sound. It is about connection — to language, to people, to opportunity. For the 63 million Indians living with significant hearing loss, the gap between where they are and a full hearing life has never been smaller than it is today.

The Cochlear Nucleus Nexa System is the most significant advance in cochlear implant technology in a generation. By making the implant itself upgradeable — firmware-driven, memory-enabled, diagnostically intelligent — Cochlear has turned what was once a static device into a living platform for hearing innovation.

For patients across Chennai, Tamil Nadu, Bhubaneswar, Odisha, Siliguri and beyond, this technology is no longer a distant global promise. It is available now, through specialist care you can trust.

If you or a loved one is experiencing hearing loss, the single most important thing you can do is seek an expert evaluation. The earlier the assessment — especially for children — the wider the door to a full hearing life.

 

Consult Dr. Sanjeev Mohanty Senior Consultant & Head, ENT Department  |  MGM Healthcare, Chennai ENT / Otorhinolaryngologist & Head and Neck Surgeon Cochlear Implant Evaluation & Surgery for Patients from Chennai  |  Bhubaneswar  |  Tamil Nadu  |  Odisha  |  Siliguri  |  India >> Book Your Consultation Today  |  [097910 74677] <<

Follow Us:

1. Facebook: www.facebook.com/entdrmohanty

2. Instagram: www.instagram.com/entdrmohanty

3. Blog: www.drmohantyss.blogspot.com

4. X: www.x.com/entdrmohanty

5. LinkedIn: www.linkedin.com/company/entdrmohanty

6. Website: www.drsanjeevmohanty.com

7. YouTube: www.youtube.com/@entdrmohanty